KRISTEN RICCIARDI: Open Payments
NPI 1003290495 · DUNMORE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,395 in 65 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $16 · 2025 $1,395
Food & beverage: $1,395
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $352 |
| Novo Nordisk Inc | 16 | $279 |
| GlaxoSmithKline, LLC. | 8 | $149 |
| Lilly USA, LLC | 9 | $137 |
| ABBVIE INC. | 4 | $103 |
| Axsome Therapeutics, Inc. | 4 | $80 |
| Exact Sciences Corporation | 3 | $79 |
| Amgen Inc. | 4 | $77 |
| Dexcom, Inc. | 3 | $59 |
| Phathom Pharmaceuticals, Inc. | 2 | $39 |
Products named: BREZTRI, Ozempic, FARXIGA, JARDIANCE, Auvelity, AREXVY, TRELEGY ELLIPTA, Rybelsus.
Industry payments across PA — which companies pay providers there.
